Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
The Food and Drug Administration recently approved a new drug made by Miami-based Opko Health.
As prescription drug prices continue to rise, employers are finding greater need to initiate expense saving methods to keep costs controlled.
CytoSorbents, a critical care immunotherapy company based in Monmouth Junction, N.J., is the recipient of a $150,000 phase I Small Business Technology Transfer contract to develop a blood purification technology that may create universal plasma.
Anthem has made it easier for health plan members to receive HIV/AIDS specialty medications, no longer requiring members to obtain the drugs through a mail order program.
To get a more accurate read of the effectiveness of any treatment being tested in an FDA-approved clinical trial, the agency is seeking comment from clinicians on how to keep researchers honest about the populations that make up study cohorts.
The U.S. Department of Veteran Affairs will partner with Underwriters Laboratories, a global safety science organization based in Northbrook, Ill., to improve cybersecurity for medical devices through a Cooperative Research and Development Agreement.
The Food and Drug Administration approved VentureMed Group's new surgical device to treat peripheral artery disease.
Patient Power, a global provider of educational audio and video content for people with cancer, surveyed more than 1,000 cancer patients and found that 1/3 of them undergo financial strain as a result of high drug costs.
The Texas Medical Center accelerator program facilitates the development of digital health and medical device companies at the world's largest medical center located in Houston.
The federal government turned down a petition to lower the price of a $129,000 drug used to treat advanced prostate cancer, according to ABC News.